Market Tracker

04/28 5:16pm ET

Novo Nordisk A/S (NYSE:NVO)

38.68
Delayed Data
As of Apr 28
 -0.10 / -0.26%
Today’s Change
30.89
Today|||52-Week Range
57.44
+7.86%
Year-to-Date

Today’s Trading

Previous close38.78
Today’s open38.90
Day’s range38.32 - 39.02
Volume2,922,841
Average volume (3 months)2,415,462
Market cap$74.1B
Dividend yield3.47%
Data as of 4:03pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+3.81%
P/E ratio2.6
Price/Sales5.48
Price/Book15.09

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.01-0.02%
AZNAstraZeneca-0.61-1.98%
AGNAllergan+0.81+0.33%
LLYEli Lilly and Co+0.73+0.90%
Data as of 4:03pm ET, 04/28/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.52
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts